Menu UF Health Home Menu
 
Capture

Brusko Lab Defines Distict Treg Subsets

TIGIT and CD226 provide important phenotypic markers for assessing the role of Tregs in health and disease

ATGGCSF

UFDI Clinical Trial Shows Promising Results

Immune therapy for treating type 1 diabetes challenges existing paradigms

Helmsley Press Release

Helmsley Grant to UFDI

During a live webinar on December 18, physicians and medical researchers from around the globe learned that a $3.3MM grant will be awarded to nPOD collaborators at UM and UF.

Focused on diabetes

Our Research Focus

Our laboratory aims to harness the power regulatory T-cells to control unwanted immune responses to deliver a cure for type 1 diabetes.

20150423 Gennie 3

Our Staff

From undergraduate students to post-doctoral fellows – every set of hands is important.

Pubs

Our Publications

View how Dr. Brusko’s research has progressed and see where our research currently stands.

Prev Next

Contact Us

Discovery consists of seeing what everybody has seen and thinking what nobody has thought

-Albert Szent-Gyorgyi